SB 1011 requires medical examiners in Arizona to conduct autopsies for sudden, unexplained infant deaths and follow specific protocols. It mandates reviewing the infant’s immunization history and recent medical treatments, then reporting all such cases to a national registry aligned with CDC guidelines. The bill directly affects infants experiencing unexplained deaths, their families, and county medical examiners who must implement these procedures. If passed, it would standardize investigations for these cases but does not change prevention or treatment policies. (Note: This is a proposed bill, as it is currently prefiling with no enacted status.)
This bill establishes rules for overdose and disease prevention programs in Arizona, allowing cities, counties, and local health departments to operate services that provide free needles, naloxone for overdose reversal, and referrals to treatment. The legislation requires these programs to offer educational materials on preventing infections and injuries while mandating that the number of needles disposed of equals the number distributed to ensure safety. Additionally, the bill creates a new fund to support rural health initiatives, requiring the state to hold public meetings in major metropolitan areas to gather community input before spending the allocated money. Finally, it explicitly prohibits the use of opioid settlement funds to finance safer smoking equipment, clarifying that such funds cannot be used for tools designed to reduce health risks associated with inhaling drugs.
This bill (SB 1178) clarifies the scope of practice for naturopathic physicians in Arizona regarding drug administration. It specifically defines which drugs and treatments naturopathic doctors may administer intravenously without requiring a prescription, excluding controlled substances, cancer chemotherapeutics, and antipsychotics. The key provision exempts vitamins, minerals, and nutrients (when manufactured/registered per federal standards) from being classified as "legend drugs" for IV use, allowing these treatments under defined conditions. The bill directly affects licensed naturopathic physicians practicing in Arizona by standardizing their permitted drug administration practices.
SB 1100 establishes new patient rights in Arizona, requiring health professionals to act in the patient's best interest, avoid causing harm, and obtain informed consent for non-emergency medical procedures. The bill defines "health professional" and "patient" to clarify who is covered by these requirements. It directly affects all patients receiving health care services in Arizona and the health care providers delivering those services. The law mandates informed consent for treatments and procedures (excluding emergencies), setting clear standards for patient-centered care.
HB 2176 updates Arizona's healthcare facility licensing rules to strengthen patient safety protections. It allows the state to deny new licenses or block ownership changes if applicants or their business associates have had licenses revoked, suspended, or faced serious safety violations in the past. The bill also limits complaint investigations to violations occurring within 12 months of the complaint date and requires clear deficiency statements with a formal dispute process for facilities to challenge findings. These changes directly affect healthcare facilities seeking new licenses, undergoing ownership transitions, or responding to complaints.
This bill updates Arizona's rules for prescribing controlled substances, requiring pharmacies to maintain separate records for different drug schedules (I-II vs. III-V) and mandating electronic prescriptions for opioids. It sets strict requirements for emergency dispensing, verbal prescription changes, and prohibits refills for Schedule II drugs. These rules directly affect pharmacies, pharmacists, and prescribers of controlled substances. The changes aim to improve tracking and reduce diversion of high-risk medications.
HB 2308 bans dental insurers and holding companies from owning dental practices registered with Arizona's Board of Dentistry. This directly affects dental practice businesses and dental insurers seeking ownership, prohibiting any ownership interest by these entities in registered practices. The key provision (Section O) adds a new restriction to existing registration rules, preventing insurers from controlling dental service businesses. The bill maintains existing registration requirements for dental practices but explicitly bars ownership by dental insurers or their holding companies.
HB 2693 amends Arizona law to clarify and expand how "bona fide associations" can offer health insurance, primarily affecting small businesses and sole proprietors. It creates two types of qualifying associations: Path 1 (requiring specific membership rules and non-discrimination in coverage) and Path 2 (for associations meeting federal standards, allowing sole proprietors and "working owners" to access group plans without standard small-group requirements). The bill ensures these associations cannot deny coverage based on health status and mandates clear disclosure of coverage terms in all materials. It also specifies that associations meeting federal criteria, like chambers of commerce, can operate self-funded health plans under certain conditions.
HB 2440 establishes a 90-day community transition program for eligible Arizona inmates, requiring the Department of Corrections to partner with private or nonprofit entities to provide services like job placement, substance abuse treatment, and family reunification counseling. To qualify, inmates must meet specific criteria (e.g., no recent violent convictions or felony detainers) and agree to provide information for a department report, while victims must receive notice before release. The bill mandates annual reporting on recidivism rates, program participation, and service types, with special provisions allowing eligibility for some inmates convicted of certain drug offenses. It also allows a one-time 90-day extension for inmates needing additional support to address specific risk factors.
HB 2049 allows rural Arizona hospitals (with under 400,000 residents or designated as critical access hospitals) to use particle accelerators for cancer treatment under "general supervision" instead of requiring a doctor's constant presence. It requires hospitals to establish written treatment protocols reviewed annually, have doctors observe technicians every six months, and ensure doctors are available on-site at least once weekly for patient care. The bill directly affects rural hospitals and radiation therapy technologists by expanding access to cancer treatment while maintaining safety through documented protocols and oversight. This policy change aims to improve cancer care access in underserved areas without altering existing federal regulations.